Evidence map›Paper›PMID 30721991›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2020

Tracking Multimorbidity Changes in Diverse Racial/Ethnic Populations Over Time: Issues and Considerations.

Ana R Quiñones, Heather G Allore, Anda Botoseneanu, Jason T Newsom, Corey L Nagel, David A Dorr

Abstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cohort Trends in the Burden of Multiple Chronic Conditions Among Aging U.S. Adults.The journals of gerontology. Series B, Psychological sciences and social sciences · 2022
    Article
  6. Physical Activity as a Mediator Between Race/Ethnicity and Changes in Multimorbidity.The journals of gerontology. Series B, Psychological sciences and social sciences · 2022
    Article
  7. Multimorbidity.Nature reviews. Disease primers · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana R QuiñonesDepartment of Family Medicine, Oregon Health & Science University, Portland, Oregon.
Heather G AlloreDepartment of Internal Medicine, Yale University, New Haven, Connecticut.
Anda BotoseneanuDepartment of Health & Human Services, University of Michigan, Dearborn, Michigan.
Jason T NewsomDepartment of Psychology, Portland State University, Portland, Oregon.
Corey L NagelCollege of Nursing, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
David A DorrDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon.

Funding

Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Albert C Shaw · 2002 to 2026
$37.9M
Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER, CHRISTOPHER H VAN DYCK · 2020 to 2026
$30.2M
Changes in Multimorbidity and Disability Among Race/Ethnic Older Adults (Administrative Supplement)R01AG055681 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI QUINONES, ANA ROMAN · 2017 to 2021
$2.8M
Research Training in Disability &Disabling DisordersK24AG021507 · NIA · YALE UNIVERSITY · PI GILL, THOMAS MICHAEL · 2003 to 2012
$1.6M
Individualized Absolute Risk calculator For Persons With Multiple Chronic ConditionsR01AG047891 · NIA · YALE UNIVERSITY · PI ALLORE, HEATHER GWYNN · 2015 to 2017
$990k
NIA NIH HHS K24 AG021507NIA NIH HHS P30 AG021342NIA NIH HHS P30 AG066508NIA NIH HHS R01 AG047891NIA NIH HHS R01 AG055681
6 · The paper itself

Abstract

Multimorbidity is widely recognized as having adverse effects on health and wellbeing and may threaten the ability of older adults to live independently. Much of what is known about multimorbidity rests on research that has largely focused on one point in time, or from a static perspective. Given that there remains a lack of agreement in the field on how to standardize multimorbidity definitions and measurement, it is not surprising that analyzing and predicting multimorbidity development, progression over time, and its impact are still largely unaddressed. As a result, there are important gaps and challenges to measuring and studying multimorbidity in a longitudinal context. This Research Practice perspective summarizes pressing challenges and offers practical steps to move the field forward.

Indexed as

AgedChronic DiseaseDisease ProgressionFemaleHumansLongitudinal StudiesMaleMultimorbiditySeverity of Illness IndexTime FactorsChronic diseasesComorbidityLongitudinalMultimorbidityMultiple chronic diseases

Identifiers

PMID30721991
PMCPMC7176055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.